Two-Hour Improvement of Patients in the National Institute of Neurological Disorders and Stroke Trials and Prediction of Final Outcome | Zendy

Thomas Hemmen | Zendy; Karin Ernström | Zendy; Rema Raman | Zendy

Open Access

Two-Hour Improvement of Patients in the National Institute of Neurological Disorders and Stroke Trials and Prediction of Final Outcome

Author(s) -

Thomas Hemmen,

Karin Ernström,

Rema Raman

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.608919

Subject(s) - medicine , modified rankin scale , stroke (engine) , confounding , tissue plasminogen activator , thrombolysis , clinical trial , acute stroke , receiver operating characteristic , placebo , physical therapy , ischemic stroke , ischemia , mechanical engineering , alternative medicine , pathology , myocardial infarction , engineering

Ongoing clinical trials are using early response to intravenous tissue-type plasminogen activator (tPA) to stratify patients into endovascular therapies. Little is known about the likelihood of early recovery and its correlation with final stroke outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research